Chiba Cancer Center
In research, Chiba Cancer Center stands highest in Medicine (#7,641 of 10,443 worldwide) and Health Sciences (#9,486 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery — Oncology is 15.1× its share of world research.
- World rank, 2022–2025
- #10,718 of 28,054 · #13,514 all time
- Rank in Japan
- #268 of 1,070
- Research works
- 1.7k ▲ 7% vs 2013–17
- Citations
- 33k 19.6 per fractional work
- Top-10% rate
- 11.0% record average 16.5%
- Open access
- 41% world 28%
What is Chiba Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,641 of 10,443 | 9.8% | 127 | #6582 | |
| Health SciencesDomain | #9,486 of 11,982 | 9.6% | 130 | #8819 |
Each strip is that field’s whole ranked pool, with the notch where Chiba Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Chiba Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 15.1× the share of its output that it takes of world research.
- OncologySubfield · 30.4 works15×
- Pulmonary and Respiratory MedicineSubfield · 26.5 works9.7×
- SurgerySubfield · 26.5 works6.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.
- Immunology and Microbiology 5.0×
- Medicine 3.7×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Nursing 0.8×
- Veterinary 0.8×
- Dentistry 0.5×
- Neuroscience 0.4×
- Physics and Astronomy 0.4×
- Chemistry 0.4×
- Health Professions 0.3×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Materials Science 0.0×
- Computer Science 0.0×
- Mathematics 0.0×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
Who are the top researchers at Chiba Cancer Center?
Ranked on the composite score, Shuichi Hironaka, Hiroki Nagase and Akira Nakagawara lead among researchers whose main affiliation is Chiba Cancer Center.
- 1 Shuichi Hironaka Japan · #52,445 worldwide 312 citations · 38 works
- 2 Hiroki Nagase Japan · #111,917 worldwide 324 citations · 42 works
- 3 Akira Nakagawara Japan · #111,942 worldwide 326 citations · 71 works
- 4 Tetsuo Ueno Japan · #208,272 worldwide 74 citations · 31 works
- 5 Kazuo Hatano Japan · #389,559 worldwide 56 citations · 49 works
- 6 Shigeru Sakiyama Japan · #486,375 worldwide 111 citations · 19 works
- 7 Miki Ohira Japan · #514,374 worldwide 99 citations · 38 works
- 8 Keizo Takenaga Japan · #518,919 worldwide 78 citations · 30 works
- 9 Nobuhiro Takiguchi Japan · #718,857 worldwide 27 citations · 33 works
- 10 Akihiro Cho Japan · #721,390 worldwide 8 citations · 21 works
Which keywords describe research at Chiba Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Prognostic Factors, Neoadjuvant Therapy, Tumor Microenvironment, Survival Analysis and Radiotherapy.
- Cancer Immunotherapy
- Barrett's Esophagus
- Precision Medicine
- Lymph Node Dissection
- Neoadjuvant Chemotherapy
- PD-1 and PD-L1
- Soft Tissue Sarcoma
- Metastasis
- Surgery
- Gene Expression
- Molecular Characterization
- Preoperative Chemoradiotherapy
- Complications
- Clinical Trials
- Targeted Therapy
- Radiotherapy
- Cancer
- Neoadjuvant Therapy
- Immunotherapy
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Prognostic Factors
- Tumor Microenvironment
- Survival Analysis
- Inflammation
- Endoscopic Resection
- Quality of Life
- Adjuvant Therapy
- Gastric Cancer
- Surgical Management
- Chemoradiation
- Genetic Mutations
- Osteosarcoma
- Immune Checkpoint Blockade
- Molecular Subtypes
- Breast Cancer
- Metastatic Gastric Cancer
- Tumor Markers
- Esophageal Carcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy27▲ 22×20 topics
- Clinical Practice Guidelines18▲ 19×13 topics
- Epidemiology16▲ 2.3×47 topics
- Immunotherapy15▲ 12×16 topics
- Prognostic Factors15▲ 19×12 topics
- Neoadjuvant Therapy13▲ 30×5 topics
- Tumor Microenvironment12▲ 15×7 topics
- Cancer11▲ 4.5×34 topics
- Survival Analysis11▲ 22×6 topics
- Radiotherapy11▲ 15×11 topics
- Inflammation10▲ 2.6×35 topics
- Targeted Therapy9▲ 23×4 topics
- Endoscopic Resection9▲ 51×2 topics
- Clinical Trials7▲ 6.0×9 topics
- Quality of Life7▲ 2.8×15 topics
- Complications7▲ 7.7×10 topics
- Adjuvant Therapy7▲ 29×2 topics
- Preoperative Chemoradiotherapy6▲ 46×2 topics
- Gastric Cancer6▲ 31×3 topics
- Molecular Characterization6▲ 20×5 topics
- Surgical Management6▲ 8.4×10 topics
- Gene Expression6▲ 5.5×11 topics
- Chemoradiation6▲ 48×2 topics
- Surgery5▲ 8.6×6 topics
- Genetic Mutations5▲ 6.9×13 topics
- Metastasis5▲ 8.8×9 topics
- Osteosarcoma5▲ 61×1 topic
- Soft Tissue Sarcoma5▲ 53×1 topic
- Immune Checkpoint Blockade5▲ 26×1 topic
- PD-1 and PD-L15▲ 26×1 topic
- Molecular Subtypes5▲ 32×3 topics
- Neoadjuvant Chemotherapy5▲ 33×2 topics
- Breast Cancer5▲ 11×9 topics
- Lymph Node Dissection5▲ 45×1 topic
- Metastatic Gastric Cancer5▲ 45×1 topic
- Precision Medicine5▲ 5.6×7 topics
- Tumor Markers5▲ 32×2 topics
- Barrett's Esophagus4▲ 60×1 topic
- Esophageal Carcinoma4▲ 60×1 topic
- Cancer Immunotherapy4▲ 15×3 topics
Which research topics does Chiba Cancer Center publish most on?
By volume in 2022–2025: Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes and Esophageal Cancer Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 5 works
- 4 Esophageal Cancer Research and Treatment Surgery 4 works
- 5 Pancreatic and Hepatic Oncology Research Oncology 4 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 7 Cancer Genomics and Diagnostics Cancer Research 3 works
- 8 Colorectal Cancer Treatments and Studies Oncology 2 works
- 9 Lung Cancer Research Studies Oncology 2 works
- 10 Breast Cancer Treatment Studies Cancer Research 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Chiba Cancer Center's research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chiba
- Chiba University
- Tokyo Dental College
- National Institutes for Quantum Science and Technology
- Chiba University Hospital
- Tokyo University of Information Sciences
- Zen-Noh (Japan)
- The Open University of Japan
- Chiba Hokusou Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.